Skip to content

Evaluating the Diagnostic Performance of ACS Using NIRS in Traumatized Lower Extremities

Evaluating the Diagnostic Performance of Near Infrared Spectroscopy (NIRS) in the Setting of Acute Compartment Syndrome (ACS) in Traumatized Lower Extremities

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03604029
Enrollment
300
Registered
2018-07-27
Start date
2019-01-07
Completion date
2022-02-28
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Compartment Syndrome of Leg

Keywords

ACS

Brief summary

This is a study intended to validate a new set of guidelines for a device that uses light to measure the amount of oxygen in the muscles of injured and non-injured legs and forearms in specific situations.

Detailed description

This is a study intended to validate a new set of guidelines for a device that uses light to measure the amount of oxygen in the muscles of injured and non-injured legs and forearms in specific situations. The name of this technology is NIRS (near-infrared spectroscopy). We have shown NIRS can be helpful in diagnosing ACS. We think two of the primary advantages of this device are that it is noninvasive (not painful) and it collects data continuously, so that if the disease develops, it can be detected early and treated appropriately. We have studied the capabilities of NIRS for many years. The last step in the process of proving NIRS and its use in ACS will be to test our recommendations and guidelines. The goal of this study is to test and prove our clinical guidelines we developed through previous work. This is an interventional study, which means the data we collect will be used to manage the patient and their care.

Interventions

DEVICENear Infrared Spectroscopy

Near Infrared Spectroscopy (NIRS) sensors are applied to injured leg compartments and a control compartment to continuously measure tissue oxygenation.

Sponsors

Nonin Medical, Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18 to 65 years 2. Ability to be enrolled within 12 hours of qualifying injury 3. Must have at least one uninjured upper or lower extremity 4. Must have a severe leg injury meeting one of the following anatomical locations and mechanisms of injury. Anatomic Location: 1. Tibia/fibula shaft fracture 2. Tibial plateau fracture (including lateral split depression, lateral depression, medial plateau, bicondylar, and bicondylar with metaphyseal extension) 3. Gunshot wound to leg without tibia fracture High Energy Mechanism of Injury (MOI): 1. Fall from more than 5-foot height 2. Motor vehicle collision (more than 15mph) 3. Motor vehicle versus pedestrian accident 4. High velocity gunshot wound (with or without tibia fracture) 5. Crush injury 6. Sport/recreation

Exclusion criteria

1. Application of NIRS monitoring would be an impediment to care 2. Known prior injury, surgery, or disease of the lower extremity (including thigh) that alters normal circulation in the leg (including peripheral vascular disease) 3. Admission for atraumatic medical reasons (i.e. myocardial infarction, sepsis) 4. Consent cannot be obtained from the patient or their LAR within 12 hours of injury 5. Has already undergone fasciotomy of the injured leg prior to enrollment 6. Has spinal injuries that result in complete loss of function (complete spinal cord injuries) 7. Has bilateral upper and lower extremity injuries greater than simple soft tissue injuries 8. Is in police custody at presentation to the hospital 9. Is a woman who is pregnant 10. Has open injury on the injured leg that is large enough that at least two NIRS sensor cannot be safely placed. At a minimum two sensors must be placed on the injured leg(s).

Design outcomes

Primary

MeasureTime frameDescription
Acute Compartment SyndromeZero to seventy two hours from enrollment.The subject develops and diagnosed with Acute Compartment Syndrome

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026